Tuesday, October 18, 2022 from 10:15 AM to 11:45 AM PDT at Continental Ballroom 6
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-182-L03-P
Activity Type: A Knowledge-Based Activity
This learning session provides an overview of key legislative opportunities to leverage the pharmacy workforce and advance medication optimization, e.g. Cures 2.0 and Equitable Community Access to Pharmacist Services (ECAPS), as well as state legislative efforts to advance recognition, coverage, and payment for clinical pharmacy services (Colorado SB94 and HB 1275). Through active discussion with expert panelists, attendees will evaluate the potential impact of comprehensive medication management (CMM) on chronic care management and acquire advocacy resources for advancing clinical pharmacist integration into value-based care team models consistent with the Affordable Care Act and its authorization of the CMS Innovation Center (CMMI). Speakers will provide a summary of these resources, and panelists will discuss how these can be applied to advocate for payment and policy reform and engage key stakeholders.
| Moderator: John K. McGlew Director, Government Affairs, American College of Clinical Pharmacy (ACCP), Washington, D.C. View Biography |
Learning Objectives
1. Outline the policy principles of ACCP’s advocacy platform to establish formal, statutory coverage for comprehensive medication management (CMM) services as it relates to the Social Security Act.
2. Discuss the importance of state-based advocacy and the potential implications of upcoming 2022 midterm elections.
3. Explain the legislative advancements of SB 21-094 and HB21-1275 in Colorado and their potential impact on the advancement of clinical pharmacy practice.
4. Identify future opportunities and barriers in the implementation of SB21-094 and HB21-1275.
5. Summarize the key components of the Maryland Primary Care Program and the implementation of comprehensive medication management in a diversity of practice models.
6. Discuss the opportunities for clinical pharmacists and collaborative practice in CMMI models and other value-based payment initiatives.